UK
UK
Nov-08
Endocrinology Pharmacoepidemiology
Read moreSep-08
Endocrinology Healthcare Cost Pharmacoepidemiology
Read moreSep-08
Endocrinology Pharmacoepidemiology
Read moreAug-08
Cardiovascular Endocrinology Pharmacoepidemiology
Read moreAug-08
Endocrinology Nephrology Pharmacoepidemiology
Read moreJul-08
Dec-07
Endocrinology Pharmacoepidemiology
Read moreNov-07
Endocrinology Healthcare Cost Pharmacoepidemiology
Read moreSep-07
Aug-07
| Date | Title | Categories | |
|---|---|---|---|
| Nov-08 | Switching From Premixed Insulin to Insulin Glargine-Based Regimen Improves Glycaemic Control in Patients with Type 1 or Type 2 Diabetes: a Retrospective Primary Care-Based Analysis | Read more | |
| Sep-08 | The relative cost effectiveness of insulin glargine versus detemir insulin using UK real life data in patients with type 2 diabetes mellitus | Read more | |
| Sep-08 | Diabetes in the UK: trends in the prevalence, incidence and treatment 1996-2005 | Read more | |
| Sep-08 | Clinical effectiveness of oral antidiabetic drugs and insulin in the management of type 2 diabetes in UK primary care – a UK population based study | Read more | |
| Aug-08 | Association between serious ischemic cardiac outcomes and medications used to treat diabetes | Read more | |
| Aug-08 | Risk of chronic end stage renal disease after use of ACE inhibitors compared to other antihypertensives or no-antihypertensive use in a cohort of diabetic patients in the United Kingdom | Read more | |
| Jul-08 | Association between renal failure and foot ulcer or lower-extremity amputation in patients with diabetes | Read more | |
| Jan-08 | Diabetes Diagnosis, Resource Utilization, and Health Outcomes | Read more | |
| Dec-07 | Delayed initiation of subcutaneous insulin therapy after failure of oral glucose-lowering agents in patients with Type 2 diabetes: a population-based analysis in the UK | Read more | |
| Nov-07 | The Relative Cost Effectiveness of Insulin Glargine Versus NPH Insulin Using UK Real Life Data in Type 1 Diabetes Mellitus and the Combined Effect of HBA1C and Hypoglycaemia Reduction | Read more | |
| Sep-07 | Clinical utility of indentifying metabolic syndrome (MetS) in patients with type 2 diabetes for primary cardiovascular disease (CVD) prevention: a population-based study | Read more | |
| Aug-07 | Combining Population Health and Baseline Risk Strategy by Determining an Age Cutoff for Initiating Statins in Patients With Diabetes | Read more |
